COLchicine Versus Ruxolitinib and Secukinumab in Open-label Prospective Randomized Trial in Patients With COVID-19
Clinical trial NCT04403243 · COMPLETED
Trial details
- NCT number
- NCT04403243
- Sponsor
- Lomonosov Moscow State University Medical Research and Educational Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-08
- Primary completion
- 2020-07-22
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.